Australia markets closed

Panbela Therapeutics, Inc. (PBLA)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.40000.0000 (0.00%)
At close: 09:45AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-27,270
-25,263
-34,933
-10,135
-4,768
-
Stock-based compensation
746
823
1,088
1,287
1,205
-
Change in working capital
1,804
-647
559
1,603
-188
-
Accounts payable
1,459
7,060
2,249
631
-747
-
Other working capital
-24,890
-25,249
-15,936
-7,245
-3,854
-
Other non-cash items
230
238
273
-
-
2,180
Net cash provided by operating activities
-24,890
-25,249
-15,276
-7,245
-3,854
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-660
-
-
-
Other investing activities
-
-
-
-540
-
-
Net cash used for investing activities
-
400
-656
0
0
-
Cash flows from financing activities
Debt repayment
-1,000
-1,650
0
0
-860
-
Common stock issued
15,777
23,053
5,349
9,054
11,081
-
Common stock repurchased
-6
-10
-
-
-
-
Net cash used provided by (used for) financing activities
19,520
26,142
5,354
10,096
10,444
-
Net change in cash
-4,973
1,293
-10,582
2,845
6,573
-
Cash at beginning of period
5,235
1,285
11,867
9,022
2,449
-
Cash at end of period
265
2,578
1,285
11,867
9,022
-
Free cash flow
Operating cash flow
-24,890
-25,249
-15,276
-7,245
-3,854
-
Capital expenditure
-
-
-660
-
-
-
Free cash flow
-24,890
-25,249
-15,936
-7,245
-3,854
-